Jump Financial, LLC Concert Pharmaceuticals, Inc. Transaction History

Jump Financial, LLC

  • $4.56 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
SELL
$4.34 - $5.84 $94,533 - $127,206
-21,782 Reduced 60.17%
14,418 $84,000
Q3 2022

Nov 07, 2022
BUY
$4.27 - $7.2 $154,573 - $260,640
36,200 New
36,200 $243,000
Q3 2021

Nov 12, 2021
SELL
$3.17 - $4.15 $115,809 - $151,611
-36,533 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$3.77 - $5.24 $137,729 - $191,432
36,533 New
36,533 $154,000

Others Institutions Holding CNCE

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About CONCERT PHARMACEUTICALS, INC.

CNCE Quotes by TradingView
  • Ticker CNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,934,600
  • Description
  • Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...
More about CNCE
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email